cgd | R Documentation |
Dataset from Fleming and Harrington (1991).
Data from a multicenter placebo-controlled randomized trial of gamma
inferon in patients with chronic granulomatous disease (CGD). 128
patients were randomized to either gamma inferon (n=63
) or
placebo (n=65
). For each patient the times from study
entry to initial and any recurrent serious infections are
available. There is a minimum of one and a maximum of eight
(recurrent) infection times per patient, with a total of 203 records.
data(cgd)
a~data frame with 203 rows and 17 columns. There are the following variables contained in the data frame.
code of the hospital
case identification number
date randomization onto study (mmddyy)
date of onset of serious infection, or date the patient was taken off the study (mmddyy)
treatment code, 1 = rIFN-gamma, 2 = placebo
pattern of inheritance, 1 = X-linked, 2 = autosomal recessive
age in years
height of the patient in cm
weight of the patient in kg
using corticosteroids at time of study entry, 1 = yes, 2 = no
using prophylatic antibiotics at time of study entry, 1 = yes, 2 = no
1 = male, 2 = female
hospital category, 1 = US-NIH, 2 = US-other, 2 = Europe - Amsterdam, 4 = Europe - other
elapsed time (in days) from randomization (from sequence = 1 record) to diagnosis of a serious infection or, if a censored observation, elapsed time from randomization to censoring date; computed as IDT - RDT (from sequence = 1 record)
0, for sequence = 1 record, if sequence > 1, T2 = T1(from previous record) + 1
censoring indicator, 1 = non-censored observation, 2 = censored observation
sequence number, for each patient, the infection recods are in sequence number order
Appendix D.2 of Fleming and Harrington (1991).
Fleming, T. R. and Harrington, D. P. (1991). Counting Processes and Survival Analysis. New York: John Wiley and Sons.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.